Literature DB >> 25598053

Surgical complications after kidney transplantation: different impacts of immunosuppression, graft function, patient variables, and surgical performance.

Martina Koch1, Alexandros Kantas, Katja Ramcke, Anna I Drabik, Björn Nashan.   

Abstract

The population of kidney transplant (KTx) recipients often has complex medical and immunological conditions. Surgical complications (SCs) contribute to the increasing morbidity and costs in these patients. We analyzed the risk factors for SC in 405 KTx patients treated using defined immunosuppressive regimens according to their clinical and immunological risk profile: (1) standard immunosuppression (SIS) with IL-2 receptor mAb, CNI, and (a) mycophenolic acid (MPA) or (b) mTOR inhibitor; and (2) more intense immunosuppression (IIS) with (a) ATG or (b) the additional use of plasma exchange and B- and T-cell-depleting agents. In a mixed effects logistic regression model, we identified the following risk factors for SC: male gender, diabetes, and post-operative dialysis. No difference was found between the patients who received SIS with MPA and those who received mTOR inhibitors. The risk of suffering complications with IIS increases with age. In addition to IIS, diabetes was a risk for wound healing disorders. Therapeutic anticoagulation and a third or subsequent retransplantation increased the rate of bleeding. We did not identify immunosuppression or patient demographics as risk factors for lymphoceles or ureter complications; however, we demonstrated that the surgeon had a significant impact on severe complications, especially those of the ureter.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  immunosuppression; kidney transplantation; surgical complications; surgical skills

Mesh:

Substances:

Year:  2015        PMID: 25598053     DOI: 10.1111/ctr.12513

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  6 in total

1.  Association of Diabetes Mellitus With Postoperative Complications and Mortality After Non-Cardiac Surgery: A Meta-Analysis and Systematic Review.

Authors:  Xiaoying Zhang; Aisheng Hou; Jiangbei Cao; Yanhong Liu; Jingsheng Lou; Hao Li; Yulong Ma; Yuxiang Song; Weidong Mi; Jing Liu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-26       Impact factor: 6.055

2.  Cholesterol Embolization Syndrome After Kidney Transplantation: A Case Series and Systematic Review.

Authors:  Marith I Francke; Marian C Clahsen-van Groningen; Thierry P P van den Bosch; Jan U Becker; Dennis A Hesselink
Journal:  Transplant Direct       Date:  2021-06-18

Review 3.  Everolimus and sirolimus in transplantation-related but different.

Authors:  Jost Klawitter; Björn Nashan; Uwe Christians
Journal:  Expert Opin Drug Saf       Date:  2015-04-26       Impact factor: 4.250

4.  The influence of the antithymocyte globulin dose on clinical outcomes of patients undergoing kidney retransplantation.

Authors:  Kamilla Linhares; Julia Bernardi Taddeo; Marina Pontello Cristelli; Henrique Proença; Klaus Nunes Ficher; Renato de Marco; Maria Gerbase-DeLima; Jose Medina-Pestana; Helio Tedesco-Silva
Journal:  PLoS One       Date:  2021-05-12       Impact factor: 3.240

5.  One-year Allograft and Patient Survival in Renal Transplant Recipients Receiving Antiplatelet Therapy at the Time of Transplantation.

Authors:  T Benkö; M Gottmann; S Radunz; A Bienholz; F H Saner; J W Treckmann; A Paul; D P Hoyer
Journal:  Int J Organ Transplant Med       Date:  2018-02-01

6.  Long-term outcome of third, fourth and fifth kidney transplantation: technical aspects and immunological challenges.

Authors:  Tamas Benkö; Patrizia Halfmann; Anja Gäckler; Sonia Radünz; Jürgen W Treckmann; Gernot M Kaiser; Dieter P Hoyer
Journal:  Clin Kidney J       Date:  2019-02-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.